ID

33351

Descripción

Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01068704

Link

https://clinicaltrials.gov/show/NCT01068704

Palabras clave

Versiones (1)
  1. 6/12/18 6/12/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

6 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01068704

Inglés

Eligibility Breast Cancer NCT01068704

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented invasive breast cancer
Descripción

Invasive carcinoma of breast

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0853879
greater than 10% tumor cells positive for estrogen receptor and/or progesterone receptor
Descripción

Neoplastic Cell Percentage Estrogen receptor positive | Neoplastic Cell Percentage Progesterone receptor positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0597032
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0279754
UMLS CUI [2,1]
C0597032
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C0279759
her2+ and her2- (human epidermal growth factor receptor) disease
Descripción

Disease HER2 Positive | Disease HER2 Negative

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348909
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C2348908
rapid disease progression despite treatment with tamoxifen, anastrozole or exemestane
Descripción

Rapid disease progression | Tamoxifen | anastrozole | exemestane

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1834700
UMLS CUI [2]
C0039286
UMLS CUI [3]
C0290883
UMLS CUI [4]
C0851344
ecog performance status = 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior hormonal therapy for metastatic disease
Descripción

Prior Hormone Therapy Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514460
UMLS CUI [1,2]
C0027627
prior hormonal therapy with letrozole for adjuvant disease
Descripción

Prior Hormone Therapy Letrozole | Other Coding

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514460
UMLS CUI [1,2]
C0246421
UMLS CUI [2]
C3846158
symptomatic brain metastases
Descripción

Metastatic malignant neoplasm to brain Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
prior treatment with any tyrosine kinase inhibitor
Descripción

Tyrosine kinase inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1268567
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01068704

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast
Item
documented invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Neoplastic Cell Percentage Estrogen receptor positive | Neoplastic Cell Percentage Progesterone receptor positive
Item
greater than 10% tumor cells positive for estrogen receptor and/or progesterone receptor
boolean
C0597032 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0279754 (UMLS CUI [1,3])
C0597032 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0279759 (UMLS CUI [2,3])
Disease HER2 Positive | Disease HER2 Negative
Item
her2+ and her2- (human epidermal growth factor receptor) disease
boolean
C0012634 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C2348908 (UMLS CUI [2,2])
Rapid disease progression | Tamoxifen | anastrozole | exemestane
Item
rapid disease progression despite treatment with tamoxifen, anastrozole or exemestane
boolean
C1834700 (UMLS CUI [1])
C0039286 (UMLS CUI [2])
C0290883 (UMLS CUI [3])
C0851344 (UMLS CUI [4])
ECOG performance status
Item
ecog performance status = 0 or 1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Hormone Therapy Neoplasm Metastasis
Item
prior hormonal therapy for metastatic disease
boolean
C1514460 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Prior Hormone Therapy Letrozole | Other Coding
Item
prior hormonal therapy with letrozole for adjuvant disease
boolean
C1514460 (UMLS CUI [1,1])
C0246421 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Tyrosine kinase inhibitor
Item
prior treatment with any tyrosine kinase inhibitor
boolean
C1268567 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial